We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

Fund managers haven’t disclosed any holdings of ARRY yet.

ARRY Hedge Fund Activity: Q4 2025 in Review

0 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q4 2025, worth a combined $0 — down 100% from $4.08K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ARRY and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Byrne Asset Management, exiting entirely with an estimated $4.08K sold.

  • 0 institutional investors held Array Biopharma Inc (ARRY) as of Q4 2025, down from 1 in Q3 2025.
  • Funds reported $0 of Array Biopharma Inc stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Array Biopharma Inc positions in Q4 2025 and 1 closed out, a net change of -1 holder.
  • The largest Array Biopharma Inc seller in Q4 2025 was Byrne Asset Management, an estimated $4.08K sold.

Based on aggregated 13F filings for Q4 2025.